If you’ve had COVID-19, even a mild case, major congratulations to you as you’ve more than likely got long-term immunity, according to a team of researchers from Washington University School of Medicine.
Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven drugs with a track record of no serious adverse events.
On December 14th, 2021, Nature Medicine released a study based on a broad population data set analyzed by researchers at Oxford University. The researchers examined the risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination and infection.
There has been conflicting data concerning Moderna’s COVID vaccine. But a Danish study published in the British Medical Journal this week showed data that found Moderna’s vaccine is more likely than Pfizer’s vaccine to cause inflammation of the heart muscle.
A pre-print November case report from the peer-reviewed journal, Frontiers in Medicine, shows the experimental Pfizer–BioNTech Covid-19 vaccine caused "rapid progression of lymphomatous lesions" in a 66-year-old man with "no significant medical history."
Health officials and vaccine makers call for boosters after studies show Pfizer vaccine is less effective against Omicron, but data on breakthrough cases suggest the vaccine hasn’t been effective against other strains, either.
